Abstract:Met tyrosine kinase receptor, also known as c-Met, is the HGF (hepatocyte growth factor) receptor. The HGF/Met pathway has a prominent role in cardiovascular remodelling after tissue injury. The present review provides a synopsis of the cellular and molecular mechanisms underlying the effects of HGF/Met in the heart and blood vessels. In vivo, HGF/Met function is particularly important for the protection of the heart in response to both acute and chronic insults, including ischaemic injury and doxorubicin-induced cardiotoxicity. Accordingly, conditional deletion of Met in cardiomyocytes results in impaired organ defence against oxidative stress. After ischaemic injury, activation of Met provides strong anti-apoptotic stimuli for cardiomyocytes through PI3K (phosphoinositide 3-kinase)/Akt and MAPK (mitogen-activated protein kinase) cascades. Recently, we found that HGF/Met is also important for autophagy regulation in cardiomyocytes via the mTOR (mammalian target of rapamycin) pathway. HGF/Met induces proliferation and migration of endothelial cells through Rac1 (Ras-related C3 botulinum toxin substrate 1) activation. In fibroblasts, HGF/Met antagonizes the actions of TGFβ1 (transforming growth factor β1) and AngII (angiotensin II), thus preventing fibrosis. Moreover, HGF/Met influences the inflammatory response of macrophages and the immune response of dendritic cells, indicating its protective function against atherosclerotic and autoimmune diseases. The HGF/Met axis also plays an important role in regulating self-renewal and myocardial regeneration through the enhancement of cardiac progenitor cells. HGF/Met has beneficial effects against myocardial infarction and endothelial dysfunction: the cellular and molecular mechanisms underlying repair function in the heart and blood vessels are common and include pro-angiogenic, anti-inflammatory and anti-fibrotic actions. Thus administration of HGF or HGF mimetics may represent a promising therapeutic agent for the treatment of both coronary and peripheral artery disease.

Expression of Hepatocyte Growth Factor and Its Receptor in Adventitial Fibroblasts and Myofibroblasts

Detection of mRNA expression of hepatocyte growth factor,its receptor and c-m et in cultured rat adventitial fibroblasts by RT-PCR

Expression of hepatocyte growth factor receptor in fibroblasts induced by high glucose

Hepatocyte Growth Factor Regulates the TGF-β1-induced Proliferation, Differentiation and Secretory Function of Cardiac Fibroblasts.

[Effects of Hepatocyte Growth Factor on TGF-beta1 Triggered Tubular Epithelial-Myofibroblast Transdifferentiation by CTGF in Vitro].

HGF/c-Met: A Key Promoter in Liver Regeneration

Expression and Function of Hepatocyte Growth Factor Activator Inhibitor Type 1

Expression and function of HGF and C-MET receptor in pterygium

[Effects of Hepatocyte Growth Factor on IL-1alpha Triggered Tubular Epithelial-Myofibroblast Transdifferentiation and Fibronectin Secretion in Vitro].

Hepatocyte growth factor in physiology and infectious diseases

Over-expression of Hepatocyte Growth Factor in Smooth Muscle Cells Regulates Endothelial Progenitor Cells Differentiation, Migration and Proliferation

Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition

Expression of Transforming Growth Factor Β 1 in Patients with Hepatocellular Carcinoma and Its Clinical Value

Cellular and molecular mechanisms of HGF/Met in the cardiovascular system

The Effection of HGF/cMet Pathway on the Expression of VEGF in MHCC97H

Progress in researches of hepatocyte growth factor and its receptor for new drug development

Effect of Hepatocyte Growth Factor on Human Renal Tubular Epithelial Cells Induced by High Glucose and Connective Tissue Growth Factor

Sustaining Effect of Gene-Transferring Hepatic Stellate Cell Strain CFSC/HGF on Hepatocytes Development

Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease.

Expression of Transforming Growth Factor a and Acidic Fibroblast Growth Factor in Hepatic Stellate Cells.

Therapeutic Effect of HGF on NASH Mice Through HGF/c-Met and JAK2-STAT3 Signalling Pathway